Company Registry

IBET Inc (AKA:Institute of Bioengineering Technologies, Inc)
Profile last edited on: 6/9/2010

instruments for the biochemical, biophysical and biomedical sciences
Year Founded
First SBIR Year
Latest SBIR Award
Program Status


Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1507 Chambers Road Suite 301
Columbus, OH 43212
   (614) 487-1379
Multiple Locations:   
Congressional District:   15
County:   Franklin

Public Profile

IBET, Inc. exploits the innovations in analytical instrumentation begun at Artann Laboratories and pursues new independently developed innovations in bioanalytical chemistry and instrumentation. IBET's facilities are equipped with all of the tools and equipment necessary for experimental biophysical chemistry and instrument development. The firm's personnel have extensive experience in biophysical chemistry and the design and construction of laboratory instrumentation, as well as the software needed to collect and analyze the forthcoming data. IBET Inc.'s corporate focus has been on research and development of instrumentation for the biochemical, biophysical, and biomedical sciences. IBET Inc. has developed analytical instruments designed to provide new and unique information about the thermodynamic properties of biologically important macromolecules and their interactions with each other and with small molecule effectors. These instruments address a deficiency in high-throughput thermodynamic methods resulting from the explosive growth in knowledge of DNA and protein sequence information. In addition to the Temperature Profile Spectroscopy instrument designed for rapid, temperature-dependent UV/Vis spectroscopy of biomacromolecules, in partnership with Artann Laboratories, IBET, Inc. has developed a Temperature-Scanning Ultrasonic Analyzer (T-SUSAN) for measurement of sound velocity in liquids employing a newly invented flow-through cylindrical standing wave ultrasonic sensor. The small volume (~tens of ml) and unique flow-through design of the ultrasonic measuring cell allow for rapid, high-precision measurements of molecular order-disorder processes of biochemical and/or pharmaceutical importance.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount Project Title
2010 2 NIH $827,515
Rapid Screening of Nucleic Acid Energetics
2009 2 NIH $845,776
Dry-reagent methods for detection of iodine in urine
2005 2 NIH $841,412
Temperature Profile Spectroscopy

Key People / Management

  George Eric Plum -- President and Chief Executive Officer

  Arman Sarvazyan -- Chairman

SBIR firms in the news

There are no news available.